| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Amino-2-norbornanecarboxylic acid | 20448-79-7 | sc-237901 | 100 mg | $182.00 | 1 | |
A competitive inhibitor of CD98 (SLC7A5), specifically blocking the transport of large neutral amino acids, which are essential for cancer cell growth and survival. | ||||||
CB 839 | 1439399-58-2 | sc-507354 | 10 mg | $140.00 | ||
A glutaminase inhibitor that indirectly targets CD98 (SLC7A5), leading to reduced glutamine uptake and limiting cancer cell proliferation and survival. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Dual inhibitor of CD98 (SLC7A5) and xCT (SLC7A11), affecting amino acid transport and redox homeostasis, leading to impaired cancer cell growth and increased sensitivity to oxidative stress. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Specifically targets the alanine-serine-cysteine transporter ASC-1 (SLC7A10), which forms a heterodimer with CD98 (SLC7A5), leading to impaired amino acid transport and affecting cancer cell metabolism. | ||||||
Canertinib | 267243-28-7 | sc-207397 | 10 mg | $260.00 | 3 | |
EGFR inhibitor that indirectly targets CD98 (SLC7A5), leading to reduced CD98-mediated amino acid transport, affecting cancer cell growth and survival. | ||||||